Sumitomo Mitsui Trust Holdings, Inc. Corcept Therapeutics Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 3,129 shares of CORT stock, worth $248,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,129
Previous 2,899
7.93%
Holding current value
$248,661
Previous $331,000
30.82%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CORT
# of Institutions
469Shares Held
83.2MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.31 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$769 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$614 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$498 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$308 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.51B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...